Chemlock Operating LLC – Trademark Portfolio
Entity Type: 16
Chemlock Operating LLC holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 6 trademarks are registered and 1 is pending. Notable registered marks include CALBAL, NUTRICOW, NUTRIVIT, NUTRIYEAST, and CALBAL [PRO]. The owner is based in West Chester Twp, OH.
9100 West Chester Towne Centre Dr.
West Chester Twp, OH 45069
Showing of trademarks Trademarks
Trademark Classifications
Chemlock Operating LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Chemlock Operating LLC have?
Chemlock Operating LLC has 10 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 pending, 3 abandoned.
What trademark classes does Chemlock Operating LLC file in?
Chemlock Operating LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Chemlock Operating LLC's most well-known trademarks?
Chemlock Operating LLC's registered trademark portfolio includes well-known marks such as CALBAL, NUTRICOW, NUTRIVIT, NUTRIYEAST, and CALBAL [PRO]. These are among 6 currently registered trademarks in the portfolio.
What is Chemlock Operating LLC's trademark registration success rate?
Chemlock Operating LLC has a 67% trademark registration rate, with 6 out of 9 resolved applications resulting in successful registration. Currently, 1 application is pending review.